Blog

 

Blog

The Repeal Bill: Understanding the small print

13 July 2017

By Charles BrastedPeter WattsJulia Marlow and Telha Arshad

The Government took the first step to implementing one of its key Brexit policies today. The long-awaited Repeal Bill, formally named the European Union (Withdrawal) Bill, which was first announced in October last year, has been published for its First Reading in the House of Commons.

The principal aim of the Bill is to transpose EU law into UK law, where practically possible, on withdrawal, thereby retaining all rules derived from EU law as they currently apply.

Read more

Jurisdictions: United Kingdom

Blog

Why the Repeal Bill is central to making Brexit a success

11 July 2017

By Peter Watts and Andrew Eaton

The Government's highly anticipated, formerly 'Great', Repeal Bill – to be published this Thursday,13 July 2017 – is likely to be the most constitutionally significant legislation enacted by the UK Parliament since the European Communities Act 1972, which took the UK into the European Economic Community and which the Repeal Bill is set to repeal and replace.

In this blog, we look ahead to what the Bill is expected to do, what happens next and the consequences of Parliament failing to pass the Repeal Bill into legislation before the UK leaves the EU.

Read more

Blog

New UK Brexit Health Alliance Formed

6 July 2017

By Jane SummerfieldHelen Kimberley and Julia Fraser

A "Brexit Health Alliance" (BHA) has been formed to bring together a diverse range of UK stakeholders in the healthcare industry and provide a single voice for the sector on Brexit-related issues. 

Read more

Industries: Life Sciences and Healthcare

Blog

Ministers provide insight on the UK's position on the regulation of medicines post-Brexit

6 July 2017

By Jane Summerfield, Helen Kimberley and Julia Fraser

With the negotiations for the UK's withdrawal from the EU formally under way, the UK healthcare sector is calling on the UK Government to make patient safety and access to medicines a priority in negotiations - and it appears from a recent letter to the Financial Times (FT) that Government ministers are listening.

Read more

Industries: Life Sciences and Healthcare

Blog

Relocation of the European Medicines Agency – France shows EMA its smooth moves

29 June 2017

By Cécile Derycke and Charles-Henri Caron

With Brexit under way, the European Medicines Agency is looking for a new home. France revealed itself as a serious contender when it considered offering not just one hosting place for the Agency, but five! Up until recently, the cities of Strasbourg (in the east), Lille (in the north), Lyon (in central France), Montpellier (in the south) and the Ile-de-France region (suburban Paris) had expressed their willingness to welcome the EMA. The EMA would have had a tough time choosing between such beautiful and different regions. Not to worry! The French government has taken the matter into its own hands and it is Lille that officially represents France and offers EMA a smooth move. Close to London, the same type of weather (i.e. easy adjustment) and warm people to welcome the EMA staff - what could be better? But obviously, this is not France's only argument; it still has several more up its sleeve. 

Read more

Industries: Life Sciences and Healthcare
Jurisdictions: France